Rishi Sunak fears prostate cancer screening decision made over flawed data model - The committee decided against rolling out wider population screening for prostate cancer through prostate specific an ...
Proteins present in men’s blood could give clues to prostate cancer risk years before diagnosis. View on euronews ...
According to Erlanger, clinical studies have shown micro-ultrasound is comparable to multiparametric MRI in detecting ...
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
Chief Medical Officer of Northwestern Medicine’s Northwest region of hospitals Dr. Irfan Hafiz joins Bob Sirott to talk about ...
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...
University Hospitals research suggests the Decipher tumor score could help doctors personalize treatment decisions for men ...
Erlanger Health has adopted ExactVu, a micro-ultrasound system providing real-time, high-resolution imaging of the prostate. "This advanced technology enhances the ability to identify areas of concern ...
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus hormone therapy compared with immediate surgery 1 Twice as many patients ...
I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about seven years. My PSA level has slowly creeped up and was recently measured ...
WTVF News Channel 5 ’s “Morningline” program interviewed Denise Garcia, MD, Assistant Professor of Surgery, about new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results